30 participants
Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-12-04
- Start Date:
- 2025-03-27
- Completion:
- 2028-02-01
Conditions
- Stage III NSCLC
Interventions
- DRUG
- PROCEDURE
- RADIATION
No Results Yet